These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31648416)

  • 1. Identification of Potential Inhibitors of Cathepsin-B using Shape & Pharmacophore-based Virtual Screening, Molecular Docking and Explicit Water Thermodynamics.
    Sharma T; Harioudh MK; Kuldeep J; Kumar S; Banerjee D; Ghosh JK; Siddiqi MI
    Mol Inform; 2020 Apr; 39(4):e1900023. PubMed ID: 31648416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer's Disease: Computational Refining and Biochemical Evaluation.
    Chitranshi N; Kumar A; Sheriff S; Gupta V; Godinez A; Saks D; Sarkar S; Shen T; Mirzaei M; Basavarajappa D; Abyadeh M; Singh SK; Dua K; Zhang KYJ; Graham SL; Gupta V
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulations.
    Sbongile M; Soliman ME
    Comb Chem High Throughput Screen; 2015; 18(4):399-410. PubMed ID: 25747438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B inhibitors: Further exploration of the nitroxoline core.
    Sosič I; Mitrović A; Ćurić H; Knez D; Brodnik Žugelj H; Štefane B; Kos J; Gobec S
    Bioorg Med Chem Lett; 2018 Apr; 28(7):1239-1247. PubMed ID: 29503024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of covalent enzyme inhibitors using virtual docking of covalent fragments.
    Chowdhury SR; Kennedy S; Zhu K; Mishra R; Chuong P; Nguyen AU; Kathman SG; Statsyuk AV
    Bioorg Med Chem Lett; 2019 Jan; 29(1):36-39. PubMed ID: 30455147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical insight into the mechanism for the inhibition of the cysteine protease cathepsin B by 1,2,4-thiadiazole derivatives.
    Vega-Teijido MA; El Chamy Maluf S; Bonturi CR; Sambrano JR; Ventura ON
    J Mol Model; 2014 Jun; 20(6):2254. PubMed ID: 24881000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cathepsin inhibitors and structure-based design of cathepsin B-specific inhibitor.
    Tomoo K
    Curr Top Med Chem; 2010; 10(7):696-707. PubMed ID: 20337581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
    Lynas JF; Hawthorne SJ; Walker B
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B-E64c complex.
    Yamamoto A; Tomoo K; Matsugi K; Hara T; In Y; Murata M; Kitamura K; Ishida T
    Biochim Biophys Acta; 2002 Jun; 1597(2):244-51. PubMed ID: 12044902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.
    Sosič I; Mirković B; Arenz K; Stefane B; Kos J; Gobec S
    J Med Chem; 2013 Jan; 56(2):521-33. PubMed ID: 23252745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis of the cathepsin B inhibitors activities through LR-MMPBSA binding affinity calculation based on docked complex.
    Zhou Z; Wang Y; Bryant SH
    J Comput Chem; 2009 Nov; 30(14):2165-75. PubMed ID: 19242965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of proteinase inhibitors in the water-soluble organic matrix from the oyster nacre.
    Bédouet L; Duplat D; Marie A; Dubost L; Berland S; Rousseau M; Milet C; Lopez E
    Mar Biotechnol (NY); 2007; 9(4):437-49. PubMed ID: 17393253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Pak1 inhibitors using water thermodynamic analysis.
    Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
    J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.
    Ménard R; Therrien C; Lachance P; Sulea T; Qo H; Alvarez-Hernandez AD; Roush WR
    Biol Chem; 2001 May; 382(5):839-45. PubMed ID: 11517939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification, characterization and optimization of small molecule probes of cysteine proteases: experiences of the Penn Center for Molecular Discovery with cathepsin B and cathepsin L.
    Huryn DM; Smith AB
    Curr Top Med Chem; 2009; 9(13):1206-16. PubMed ID: 19807666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.
    Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D
    Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current stage of cathepsin B inhibitors as potential anticancer agents.
    Kos J; Mitrović A; Mirković B
    Future Med Chem; 2014 Jul; 6(11):1355-71. PubMed ID: 25163003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput virtual screening and E-pharmacophore filtering in the discovery of new BACE-1 inhibitors.
    Muthusamy K; Singh KhD; Chinnasamy S; Nagamani S; Krishnasamy G; Thiyagarajan C; Premkumar P; Anusuyadevi M
    Interdiscip Sci; 2013 Jun; 5(2):119-26. PubMed ID: 23740393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.